Advertisement

Lasers in Medical Science

, Volume 31, Issue 8, pp 1651–1656 | Cite as

Transcranial low-level infrared laser irradiation ameliorates depression induced by reserpine in rats

  • Haitham S. MohammedEmail author
Original Article

Abstract

Transcranial low-level infrared laser is a modality of therapy based on the principle of photons delivered in a non-invasive manner through the skull for the treatment of some neurological conditions such as psychological disorders, traumatic brain injuries, and neurodegenerative diseases among others. In the present study, effects of low-level infrared laser irradiation with different radiation powers (80, 200, and 400 mW, continuous wave) were investigated on normal animals subjected to forced swimming test (FST). Results indicated that there are changes in FST parameters in animals irradiated with laser; the lowest dose provoked a significant increase in animal activity (swimming and climbing) and a significant decrease in animal’s immobility, while the highest laser dose resulted in a complete inverse action by significantly increasing animal immobility and significantly decreasing animal activity with respect to control animals. The lowest dose (80 mW) of transcranial laser irradiation has then utilized on animals injected with a chronic dose of reserpine (0.2 mg/kg i.p. for 14 days) served as an animal model of depression. Laser irradiation has successfully ameliorated depression induced by reserpine as indicated by FST parameters and electrocorticography (ECoG) spectral analysis in irradiated animals. The findings of the present study emphasized the beneficial effects of low-level infrared laser irradiation on normal and healthy animals. Additionally, it indicated the potential antidepressant activity of the low dose of infrared laser irradiation.

Keywords

Low-level infrared laser Depression FST ECoG Rat 

Notes

Acknowledgments

The author would like to thank all staff members at Basic Science Department, Faculty of physical therapy, Cairo University for their help during the course of this study.

Compliance with ethical standards

Conflict of interests

The author declares that he has no competing interests.

References

  1. 1.
    Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Mico JA (2004) Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates. J Psychopharmacol 18:404–411CrossRefPubMedGoogle Scholar
  2. 2.
    Nagakura Y, Oe T, Aoki T, Matsuoka N (2009) Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia. Pain 146:26–33CrossRefPubMedGoogle Scholar
  3. 3.
    Blasco-Serra A, Escrihuela-Vidal F, González-Soler EM, Martínez-Expósito F, Blasco-Ausina MC, Martínez-Bellver S, Cervera-Ferri A, Teruel-Martí V, Valverde-Navarro AA (2015) Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats. Physiol Behav 151:456–462CrossRefPubMedGoogle Scholar
  4. 4.
    Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354(6):579–587CrossRefPubMedGoogle Scholar
  5. 5.
    Mrazek DA, Hornberger JC, Altar AMSC, Degtiar IA (2014) Review of the clinical, economic, and societal burden of treatment resistant depression: 1996–2013. Psychiatr Serv 65(8):977–987CrossRefPubMedGoogle Scholar
  6. 6.
    Chung H, Dai T, Sharma SK, Huang YY, Carroll JD, Hamblin MR (2012) The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng 40:516–533CrossRefPubMedGoogle Scholar
  7. 7.
    Rojas JC, Gonzalez-Lima F (2013) Neurological and psychological applications of transcranial lasers and LEDs. Biochem Pharmacol 86:447–457CrossRefPubMedGoogle Scholar
  8. 8.
    Cassano P, Petrie SR, Hamblin MR, Henderson TA, Iosifescu DV (2016) Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis. Neurophotonics 3(3):031404CrossRefPubMedGoogle Scholar
  9. 9.
    Leuchter AF et al (2009) Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res 169:132–138CrossRefPubMedGoogle Scholar
  10. 10.
    Hunter AM, Leuchter AF, Cook IA, Abrams M (2010) Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment. Acta Psychiatr Scand 122:461–469CrossRefPubMedGoogle Scholar
  11. 11.
    Petit-Demouliere B, Chenu F, Bourin M (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 177:245–255CrossRefGoogle Scholar
  12. 12.
    Antkiewicz-Michaluk L, Wasik A, Mozdzen E, Romanska I, Michaluk J (2014) Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat. Neurotox Res 26:85–98CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Mohammed HS, Aboul EZZ HS, Khadrawy YA, Noor NA (2011) Neurochemical and electrophysiological changes induced by paradoxical sleep deprivation in rats. Behav Brain Res 225:39–46CrossRefPubMedGoogle Scholar
  14. 14.
    Huang YY, Chen AC-H, James D, Hamblin MR (2009) Biphasic dose response in low level light therapy. Dose-Response 7:358–383CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Barrett DW, Gonzalez-lima F (2013) Transcranial infrared laser stimulation produces beneficial cognitive and emotional effects in humans. Neuroscience 230:13–23CrossRefPubMedGoogle Scholar
  16. 16.
    Cassano P, Cusin C, Mischoulon D, Hamblin MR, De Taboada L, Pisoni A, Chang T, Yeung A, Ionescu DF, Petrie SR, Nierenberg AA, Fava M, Iosifescu DV (2015) Near-infrared transcranial radiation for major depressive disorder: proof of concept study. Psychiatry J 2015:352979CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Michalikova S, Ennaceur A, van Rensburg R, Chazot PL (2008) Emotional responses and memory performance of middle-aged CD1 mice in a 3D maze: effects of low infrared light. Neurobiol Learn Mem 89:480–488CrossRefPubMedGoogle Scholar
  18. 18.
    Huang QJ, Jiang H, Hao XL, Minor TR (2004) Brain IL-1β was involved in reserpine-induced behavioral depression in rats. Acta Pharmacol Sin 25(3):293–296PubMedGoogle Scholar
  19. 19.
    Zwierzyńska E, Krupa A, Pietrzak B (2015) A pharmaco-EEG study of the interaction between ethanol and retigabine in rabbits. Am J Drug Alcohol Abuse 41(2):153–160CrossRefPubMedGoogle Scholar
  20. 20.
    Vakalopoulos C (2014) The EEG as an index of neuromodulator balance in memory and mental illness. Front Neurosci 8:8–63CrossRefGoogle Scholar
  21. 21.
    Robbins TW, Granon S, Muir JL, Durantou F, Harrison A, Everitt BJ (1998) Neural systems underlying arousal and attention: implications for drug abuse. Ann N Y Acad Sci 846:222–237CrossRefPubMedGoogle Scholar
  22. 22.
    Olvera-Cortes E, Cervantes M, Gonzalez-Burgos I (2002) Place-learning, but not cue-learning training, modifies the hippocampal theta rhythm in rats. Brain Res Bull 58:261–270CrossRefPubMedGoogle Scholar
  23. 23.
    Jia-Y L, Terry BJK, Jiin-Cherng Y, Shih-Chih T, Cheryl CHY (2014) Voluntary and involuntary running in the rat show different patterns of theta rhythm, physical activity, and heart rate. J Neurophysiol 111(10):2061–2070CrossRefGoogle Scholar
  24. 24.
    Maina G (1974) Reserpine as an uncoupling agent. Biochim Biophys Acta 333:481–486CrossRefGoogle Scholar
  25. 25.
    Osubor CC, Nwanze EAC (1994) Inhibition of rat mitochondrial functions in vivo by 6-OHDA and reserpine. Res Exp Med 194:109–117CrossRefGoogle Scholar
  26. 26.
    El-Ghazaly MA, Sadik NAH, Rashed ER, Abd-El-Fattah AA (2015) Neuroprotective effect of EGb761® and low-dose whole-body γ-irradiation in a rat model of Parkinson’s disease. ToxicolInd Health 31(12):1128–1143Google Scholar
  27. 27.
    Eells JT et al (2004) Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion 4:559–567CrossRefPubMedGoogle Scholar
  28. 28.
    Wong-Riley MT, Liang HL, Eells JT, Chance B, Henry MM, Buchmann E, Kane M, Whelan HT (2005) Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: Role of cytochrome c oxidase. J Biol Chem 280:4761–4771CrossRefPubMedGoogle Scholar
  29. 29.
    Tian F, Hase SN, Gonzalez-Lima F, Liu H (2016) Transcranial laser stimulation improves human cerebral oxygenation. Lasers Surg Med. doi: 10.1002/lsm.22471 PubMedGoogle Scholar
  30. 30.
    Shumake J, Gonzalez‐Lima F (2003) Brain systems underlying susceptibility to helplessness and depression. Behav Cogn Neurosci Rev 2(3):198–221CrossRefPubMedGoogle Scholar
  31. 31.
    Schiffer F (2009) Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behav Brain Funct 5:46CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag London 2016

Authors and Affiliations

  1. 1.Biophysics Department, Faculty of ScienceCairo UniversityGizaEgypt

Personalised recommendations